BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15114749)

  • 1. [An expanded technique of transrectal prostatic biopsy].
    Pushkar' DIu; Govorov AV; Bernikov AN
    Urologiia; 2004; (2):31-3. PubMed ID: 15114749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for extended 14-core transrectal ultrasound-guided prostate biopsy.
    Uno H; Nakano M; Ehara H; Deguchi T
    Urology; 2008 Jan; 71(1):23-7. PubMed ID: 18242358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of parallel ultrasonic visualization of the prostate in sagittal and cross projections in transrectal biopsy on detectability of prostatic cancer].
    Pushkar' DIu; Govorov AV; Dubov SV; Denisov SA
    Urologiia; 2005; (6):13-5. PubMed ID: 16419473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1-10 ng/mL?
    Yamamoto S; Ito T; Aizawa T; Noda K; Umezu K; Ohtsuru N; Hata K
    Int J Urol; 2004 Jun; 11(6):386-91. PubMed ID: 15157207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
    Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
    Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
    Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
    Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
    NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.
    Al-Azab R; Toi A; Lockwood G; Kulkarni GS; Fleshner N
    Urology; 2007 Jan; 69(1):103-7. PubMed ID: 17270628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL.
    Ito K; Ohi M; Yamamoto T; Miyamoto S; Kurokawa K; Fukabori Y; Suzuki K; Yamanaka H
    Cancer; 2002 Nov; 95(10):2112-9. PubMed ID: 12412164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of transrectal ultrasound guided biopsy in patients over 70 years old with a prostate specific Antigen (PSA) level ≤ 15 ng/ml and normal digital rectal examination: a 10-year prospective follow-up study of 427 consecutive patients.
    Mohamed ZK; Dominguez-Escrig J; Vasdev N; Bharathan B; Greene D
    Urol Oncol; 2013 Nov; 31(8):1489-96. PubMed ID: 22591749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of prostate cancer detection rate (PCDR) in Chinese Han population under different prostate biopsy methods.
    Pan Y; Liu B; Huang Y; Wang J; Li X; Zhang C; Wu J; Zheng Y; Qin C; Cheng G; Hua L; Wang Z
    Oncotarget; 2017 May; 8(20):32930-32936. PubMed ID: 28380425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection.
    Watanabe M; Hayashi T; Tsushima T; Irie S; Kaneshige T; Kumon H
    Int J Urol; 2005 Nov; 12(11):959-63. PubMed ID: 16351651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
    Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
    Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy.
    Emiliozzi P; Scarpone P; DePaula F; Pizzo M; Federico G; Pansadoro A; Martini M; Pansadoro V
    J Urol; 2004 Jan; 171(1):197-9. PubMed ID: 14665875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systematic ultrasound guided transrectal core prostate biopsy based on serum level of prostate-specific antigen].
    Yamaguchi S; Baba Y; Naito K
    Hinyokika Kiyo; 1997 Sep; 43(9):641-5. PubMed ID: 9365843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple prostatic biopsies in the "gray zone" of the specific prostatic antigen].
    Drudi FM; Ricci P; Iannicelli E; Di Nardo R; Novelli L; Laghi A; Perugia G; Passariello R
    Radiol Med; 2000; 99(1-2):81-5. PubMed ID: 10803192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
    Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.